2022
DOI: 10.1681/asn.2021030294
|View full text |Cite
|
Sign up to set email alerts
|

Reduced Glomerular Filtration in Diabetes Is Attributable to Loss of Density and Increased Resistance of Glomerular Endothelial Cell Fenestrations

Abstract: Background: Glomerular endothelial cell (GEnC) fenestrations are recognised as an essential component of the glomerular filtration barrier, yet little is known about how they are regulated and their role in disease. Methods: We comprehensively characterized GEnC fenestral and functional renal filtration changes including measurement of glomerular ultrafiltration coefficient and glomerular filtration rate in diabetic mice (BTBR ob-/ob-). We also examined and compared human samples. We evaluated Eps homology dom… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 35 publications
0
12
0
Order By: Relevance
“…We analyzed the expression of TRPC6, LC3B, and the autophagic cargo protein sequestosome 1 (SQSTM1, also called P62) in podocytes in two murine diabetic models: ( 1 ) a type 1 diabetes mellitus model of accelerated DKD combining streptozotocin (STZ)-induced diabetes with unilateral nephrectomy 42 and ( 2 ) a type 2 diabetes model of DKD with the use of BTBR ob/ob mice. 43,44 GFP-LC3 reporter mice were used in the type 1 diabetes mellitus model to monitor the autophagic flux in vivo . 37 In both models, we demonstrated increased podocyte-specific TRPC6 expression (Figure 1, A–C).…”
Section: Resultsmentioning
confidence: 99%
“…We analyzed the expression of TRPC6, LC3B, and the autophagic cargo protein sequestosome 1 (SQSTM1, also called P62) in podocytes in two murine diabetic models: ( 1 ) a type 1 diabetes mellitus model of accelerated DKD combining streptozotocin (STZ)-induced diabetes with unilateral nephrectomy 42 and ( 2 ) a type 2 diabetes model of DKD with the use of BTBR ob/ob mice. 43,44 GFP-LC3 reporter mice were used in the type 1 diabetes mellitus model to monitor the autophagic flux in vivo . 37 In both models, we demonstrated increased podocyte-specific TRPC6 expression (Figure 1, A–C).…”
Section: Resultsmentioning
confidence: 99%
“…PLVAP was also detected at a later time point in the glomeruli of BTBR ob/ob mice [38]. A very recent paper impressively demonstrated induced PLVAP expression in glomerular capillaries of BTBR ob/ob mice and diabetic patients, corroborating the translational significance of PLVAP as a diagnostic marker in DKD [39]. However, it is still not clear whether PLVAP is mechanistically involved in the processes of injury or regeneration upon initial damage.…”
Section: Discussionmentioning
confidence: 97%
“…On the other hand, PLVAP is expressed in the glomerular endothelium during nephrogenesis [ 11 ], and embryonic processes operating during fetal life could generally be re-activated to repair damaged organs in adulthood. Moreover, it is known that endothelial fenestration in glomeruli is diminished early in DKD [ 19 , 39 ]. Since PLVAP is necessary for the functional and structural integrity of fenestrae [ 5 , 40 , 41 , 42 , 43 , 44 ], one may speculate that its induced expression counteracts the fenestral disintegration in the glomerular endothelium during DM.…”
Section: Discussionmentioning
confidence: 99%
“…The PLVAP protein is the main component of endothelial diaphragms in fenestrae, caveolae, and transendothelial channels, shown in previous studies to be associated with DKD and HCC. On the one hand, PLVAP can be used as an early marker of glomerular endothelial injury with DKD in mice ( 44 ), and do increase in glomeruli of human diabetic patients ( 45 ). On the other hand, PLVAP was identified as a gene expressed explicitly in HCC vascular endothelial cells ( 46 ), and has been investigated as a therapeutic target in HCC ( 46 ), perhaps based on its ability to alter the immunosuppressive microenvironment ( 47 ).…”
Section: Discussionmentioning
confidence: 99%